myelin

(redirected from demyelinating)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

myelin

, myeline
a white tissue forming an insulating sheath (myelin sheath) around certain nerve fibres. Damage to the myelin sheath causes neurological disease, as in multiple sclerosis

myelin

[′mī·ə·lən]
(neuroscience)
A soft, white fatty substance that forms a sheath around certain nerve fibers.
References in periodicals archive ?
The disease has clinically indistinguishable axonal, demyelinating or mixed types4.
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) with hypertrophic spinal radiculopathy mimicking neurofibromatosis.
Nerve conduction velocity assessment revealed a prolonged F wave and a motor-predominant axonal-type demyelinating polyneuropathy involving the median, ulnar, and peroneal nerves.
Tumefactive MS lesions are defined as solitary demyelinating plaques greater than 2 cm.
The report provides a snapshot of the global therapeutic landscape of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disorder of the central nervous system (CNS) predominantly affecting the white matter of brain and spinal cord.
Oligodendrocytes arc implicated in many different disorders, therefore this research not only moves multiple sclerosis research forward, it allows scientists the ability to study all demyelinating and central nervous system disorders.
She completed pediatrics training at McMaster University and pediatric neurology training at SUNY Buffalo, where she developed and co-directed the Pediatric MS and Demyelinating Disorders Center of Excellence.
Multifocal involvement strongly favors non-neoplastic lesions, such as demyelinating diseases.
Lucas' team discovered that the risk of having a first demyelinating event, which was estimated to be between two to nine cases per 100,000 people per year, was reduced by 30% for every 1,000 kilojoule increase in ultraviolet light exposure.
The panel stressed that the updated criteria should only be applied to patients who present with a typical clinically isolated syndrome (CIS) suggestive of MS or symptoms consistent with a CNS inflammatory demyelinating disease, because the development and validation of the criteria have been limited to patients with such presentations.